Is BioMarin A Buy Ahead Of This Important Data Release?

By: via Benzinga
In a report published Monday, Leerink analyst Joseph P. Schwartz reiterated an Outperform rating and price target of $136 on BioMarin ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.